Cover Image
Market Research Report
Product code 
1045335

AI in Medical Diagnostics: Global Markets

Published: | BCC Research | 240 Pages | Delivery time: 1-2 business days

Price

Back to Top
AI in Medical Diagnostics: Global Markets
Published: January 5, 2022
BCC Research
Content info: 240 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Highlights:

The global market for AI medical diagnostics is estimated to increase from $748 million in 2021 to reach $4.0 billion by 2026, at a compound annual growth rate (CAGR) of 39.8% during the forecast period of 2021-2026.

North American market for AI medical diagnostics is estimated to increase from $256 million in 2021 to reach $1.3 billion by 2026, at a CAGR of 38.1% during the forecast period of 2021-2026.

Asia-Pacific market for AI medical diagnostics is estimated to increase from $212 million in 2021 to reach $1.2 billion by 2026, at a CAGR of 41.2% during the forecast period of 2021-2026.

Report Scope:

The current report offers a detailed picture of the AI medical diagnostics market.

This report highlights the current and future market potential for AI medical diagnostics and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections through 2026, as well as key market players.

This report discusses the AI medical diagnostics market and its various resources. It covers the overall AI medical diagnostics market including hardware, software and analytics, and services. The report further analyzes the market based on application, providing an analysis of oncology, cardiology, neurology, orthopedic and others. In addition, the report also analyses various modalities of diagnostics imaging including MRI, CT scans, ultrasounds, X-rays and others (ECG, EEG, etc.). Furthermore, a complete regional analysis of the market is also studied in the report.

Based on geography, the market has been segmented into North America, Europe, Asia-Pacific and the Rest of the World (which includes Latin America, and the Middle East and Africa). Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2021 through 2026. Estimated values are based on product manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

  • 68 data tables and 67 additional tables
  • A brief general outlook of the global market for artificial intelligence (AI) in medical diagnostics
  • Analyses of the global market trends, with historic data from 2019 and 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Evaluation and forecast the global AI medical diagnostics market size, and corresponding market share analysis by component, medical specialty application area, end-user, treatment modality, and geographic region
  • Technology assessment of the key drivers, restraints and opportunities that will shape the market for AI medical diagnostics over the next five years (2021 to 2026)
  • Country specific data and market value analysis for the U.S., Canada, France, Germany, U.K., Italy, Spain, China, India, Japan and other emerging economies
  • Identification of key artificial intelligence technologies and products with the greatest commercial potential, and relevant applications of various AI tools in medical diagnosis, breakthrough therapies and patient health management
  • Highlights of the COVID-19 impact on the global AI medical diagnostics market as well as the overall MedTech industry
  • Insight into recent industry structure, current competitive scenario, R&D activities, regulatory and legislative issues, and product launch strategies currently focused on AI technologies
  • Patent activity and review of patent grants for AI medical diagnostics across each major category
  • Understanding of the start-up ecosystem and competitor dashboard for key market participants in global AI medical diagnostics market
  • Descriptive company profiles of the leading market players, including Canon Medical System Corp., GE Healthcare, Intel, IBM Corp., Nano-X Imaging Ltd., Siemens Healthcare GmbH, and Subtle Medical, Inc.
Product Code: HLC279A

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Introduction to Artificial Intelligence
  • Understanding Artificial Intelligence in Healthcare
  • Artificial Intelligence in Healthcare Evolution and Transition
  • Defining Artificial Intelligence in Medical Diagnostics
  • Disease Detection and Diagnostics
  • Industry Structure
  • Data Warehouse
  • Artificial Intelligence (AI) Analysis
  • Software Development
  • List of FDA-Approved AI and Machine Learning-Enabled Medical Devices/Diagnostics Devices and Algorithms
  • AI and Machine Learning-Enabled Medical Devices/Radiology and Other Imaging Modalities
  • Artificial Intelligence and Machine Learning (AI/ML) Algorithms

Chapter 4 Market Dynamics

  • Drivers
  • Investment in AI Health Sector
  • Increasing Strategic Moves by Market Players
  • Rising Incidence of Chronic Diseases
  • Restraints and Challenges
  • Reluctance Among Medical Practitioners to Adopt AI-Based Technologies
  • Ambiguous Regulatory Guidelines for Medical Software
  • Challenge To Maintain Data Security
  • Opportunities
  • Integration of Software with Artificial Intelligence
  • Untapped Potential in Emerging Markets

Chapter 5 Impact of COVID-19 on the AI Medical Diagnostics Market

  • Introduction
  • Regulatory Delays, Clinical Trials and Product Launches
  • Supply Chain Disruptions
  • Impact on MedTech
  • Impact on AI Medical Diagnostics
  • Home-Based Pathology

Chapter 6 Global Market for AI Medical Diagnostics by Component

  • Software
  • Services
  • Hardware

Chapter 7 Global Market for AI Medical Diagnostics by Medical Specialty Application Area

  • Oncology
  • Cardiology
  • Neurology
  • Orthopedics
  • Others

Chapter 8 Global Market for AI Medical Diagnostics by End User

  • Hospitals and Clinics
  • Diagnostic Imaging Centers and Diagnostic Laboratories

Chapter 9 Global Market for AI Medical Diagnostics by Modality

  • MRI
  • CT Scans
  • Common Applications of CT Scans
  • Application of CT in Pediatric Patients
  • Benefits
  • Ultrasound
  • X-Rays
  • Advantages of X-Ray Machines
  • Others

Chapter 10 Global Market for AI Medical Diagnostics by Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
  • Rest of the World

Chapter 11 Regulatory Framework

  • Regulatory Framework
  • American Diabetes Association's Standards of Medical Care in Diabetes
  • ATA Guidelines for Artificial Intelligence (AI)
  • Indian AI Guidelines, Strategy and Standards

Chapter 12 Patent Review

  • Introduction
  • Patent Review
  • Companies Granted Patents in AI Medical Diagnostics
  • Patent Review by Geography

Chapter 13 Start-up Ecosystem

  • Introduction

Chapter 14 Competitive Landscape Analysis

  • Primary Strategies: Partnerships, Collaborations, Agreements and Contracts
  • FDA/CE Mark/EU Approval: Secondary Strategy
  • Review of Company Strategies Used

Chapter 15 Company Profiles

  • AIDOC MEDICAL LTD.
  • ARTERYS INC.
  • BEHOLD.AI TECHNOLOGIES LTD.
  • BUTTERFLY NETWORK
  • CANON MEDICAL SYSTEM CORP.
  • CAPTION HEALTH
  • DEEPMIND TECHNOLOGIES LTD.
  • DIGITAL DIAGNOSTICS
  • ENLITIC INC.
  • FUJIFILM HOLDING CORP.
  • GE HEALTHCARE
  • HEURON CO., LTD.
  • IMAGEN TECHNOLOGIES
  • INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
  • ICARBONX
  • INTEL CORP.
  • MEDTRONIC PLC
  • MICROSOFT CORP.
  • NANO-X IMAGING LTD.
  • NVIDIA
  • PHILIPS HEALTHCARE
  • QURE.AI
  • ROCHE HOLDING AG
  • SAMSUNG ELECTRONICS INC.
  • SIEMENS HEALTHCARE
  • SUBTLE MEDICAL, INC.
  • SYNAPSICA
  • XILINX, INC.

List of Tables

  • Summary Table : Global Market for AI Medical Diagnostics, by Region, Through 2026
  • Table 1 : FDA-Cleared AI Radiology and Other Imaging Modalities in the U.S., 2018-2021
  • Table 2 : FDA-Approved AI Algorithms for Radiology and Medical Imaging in the U.S., 2018-2021
  • Table 3 : Global Leading Causes of Burden of Disease, 2004 and 2030
  • Table 4 : Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
  • Table 5 : Global Market for AI Medical Diagnostics, by Component, Through 2026
  • Table 6 : Global Market for AI Software in Medical Diagnostics, by Region, Through 2026
  • Table 7 : Global Market for AI Services in Medical Diagnostics, by Region, Through 2026
  • Table 8 : Global Market for AI Hardware in Medical Diagnostics, by Region, Through 2026
  • Table 9 : Global Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
  • Table 10 : Global Deaths from Cancer, 2015 and 2030
  • Table 11 : Global Market for AI Medical Diagnostics in Oncology, by Region, Through 2026
  • Table 12 : Recent Examples of Machine Learning in Cardiology
  • Table 13 : Global Deaths from CVD, 2015 and 2030
  • Table 14 : Global Market for AI Medical Diagnostics in Cardiology, by Region, Through 2026
  • Table 15 : Number of DALYs for Neurological Disorders and as Share of Global DALYs Projected for 2005 and 2030
  • Table 16 : Deaths Attributable to Neurological Disorders, 2005 and 2030
  • Table 17 : Global Market for AI Medical Diagnostics in Neurology, by Region, Through 2026
  • Table 18 : Global Percentage Distribution of Population Aged Above 65, by Region, 2015 and 2050
  • Table 19 : Global Market for AI Medical Diagnostics in Orthopedics, by Region, Through 2026
  • Table 20 : Global Market for AI Medical Diagnostics in Other Disease Treatments, by Region, Through 2026
  • Table 21 : Global Market for AI Medical Diagnostics, by End User, Through 2026
  • Table 22 : Number of Hospitals in the U.S., by Type, 2020
  • Table 23 : Global Market for AI in Hospitals and Clinics, by Region, Through 2026
  • Table 24 : Global Market for AI Medical Diagnostics in Diagnostic Imaging Centers and Diagnostic Laboratories, by Region, Through 2026
  • Table 25 : Global Market for AI Medical Diagnostics, by Modality, Through 2026
  • Table 26 : Global Market for AI-Based MRI Scans, by Region, Through 2026
  • Table 27 : Global Market for AI-Based CT Scans, by Region, Through 2026
  • Table 28 : Some Major Uses of Ultrasound
  • Table 29 : Global Market for AI-Based Ultrasound, by Region, Through 2026
  • Table 30 : Global Market for AI-Based X-Rays, by Region, Through 2026
  • Table 31 : Global Market for AI-Based Other Imaging Techniques, by Region, Through 2026
  • Table 32 : Global Market for AI Medical Diagnostics, by Region, Through 2026
  • Table 33 : North American Market for AI Medical Diagnostics, by Component, Through 2026
  • Table 34 : North American Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
  • Table 35 : North American Market for AI Medical Diagnostics, by Modality, Through 2026
  • Table 36 : North American Market for AI Medical Diagnostics, by End User, Through 2026
  • Table 37 : North American Market for AI Medical Diagnostics, by Country, Through 2026
  • Table 38 : Top Funded AI Start-ups in the United States, 2021
  • Table 39 : Confirmed Cases of COVID-19 in Europe, by Country, as of December, 2021
  • Table 40 : European Market for AI Medical Diagnostics, by Component, Through 2026
  • Table 41 : European Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
  • Table 42 : European Market for AI Medical Diagnostics, by Modality, Through 2026
  • Table 43 : European Market for AI Medical Diagnostics, by End User, Through 2026
  • Table 44 : European Market for AI Medical Diagnostics, by Country, Through 2026
  • Table 45 : Start-ups in the German Market for AI Medical Diagnostics
  • Table 46 : Start-ups in the French Market for AI Medical Diagnostics
  • Table 47 : Start-ups in the Spanish Market for AI Medical Diagnostics
  • Table 48 : Start-ups in the Rest of European Market for AI Medical Diagnostics
  • Table 49 : Asia-Pacific Market for AI Medical Diagnostics, by Component, Through 2026
  • Table 50 : Asia-Pacific Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
  • Table 51 : Asia-Pacific Market for AI Medical Diagnostics, by Modality, Through 2026
  • Table 52 : Asia-Pacific Market for AI Medical Diagnostics, by End User, Through 2026
  • Table 53 : Asia-Pacific Market for AI Medical Diagnostics, by Countries, Through 2026
  • Table 54 : Japanese Market Statistics
  • Table 55 : Number of New Cancer Cases in Japan in Both Sexes, by All Age Groups, 2020
  • Table 56 : Funding of AI Diagnostics Start-ups in Rest of Asia-Pacific Countries
  • Table 57 : Rest of the World Market for AI Medical Diagnostics, by Component, Through 2026
  • Table 58 : Rest of the World Market for AI Medical Diagnostics, by Medical Specialty Application Area, Through 2026
  • Table 59 : Rest of the World Market for AI Medical Diagnostics, by Modality, Through 2026
  • Table 60 : Rest of the World Market for AI Medical Diagnostics, by End User, Through 2026
  • Table 61 : Regulation Pertaining AI Medical Diagnostics Across Countries
  • Table 62 : Siemens Healthcare GmbH Patents, 2019-2021
  • Table 63 : General Electric Co. Patents, 2019-2021
  • Table 64 : Patents Granted to Other Major Market Players, 2019-2021
  • Table 65 : Start-ups Founded in the AI Medical Diagnostics Industry, 2020-2021
  • Table 66 : Major Market Strategies in Global Market for AI Medical Diagnostics, 2018-2021
  • Table 67 : List of Partnerships, Collaborations, Agreements and Contracts, 2020-2021
  • Table 68 : List of FDA, CE Mark and EU Approvals, 2020 and 2021
  • Table 69 : Aidoc Medical Ltd.: Product Portfolio
  • Table 70 : Aidoc Medical Ltd.: Strategies and Development
  • Table 71 : Arterys Inc.: Product Portfolio
  • Table 72 : Arterys Inc.: Strategies and Development
  • Table 73 : Behold.ai: Product Portfolio
  • Table 74 : Behold.ai: Strategies and Development
  • Table 75 : Butterfly Network: Product Portfolio
  • Table 76 : Butterfly Network: Strategies and Development
  • Table 77 : Canon Medical: Company Financials, 2019 and 2020
  • Table 78 : Canon Medical System: Product Portfolio
  • Table 79 : Canon Medical System: Strategies and Development
  • Table 80 : Caption Health: Product Portfolio
  • Table 81 : Caption Health: Strategies and Developments
  • Table 82 : DeepMind: Company Financials, 2020-2019
  • Table 83 : DeepMind: Product Portfolio
  • Table 84 : Digital Diagnostics: Product Portfolio
  • Table 85 : Digital Diagnostics: Strategies and Developments
  • Table 86 : Enlitic Inc.: Product Portfolio
  • Table 87 : Fujifilm Holding Corp.: Company Financials, 2019 and 2020
  • Table 88 : Fujifilm Holding Corp.: Product Portfolio
  • Table 89 : Fujifilm Holding Corp.: Strategies and Developments
  • Table 90 : GE: Financial Performance, 2019 and 2020
  • Table 91 : GE Healthcare: Product Portfolio
  • Table 92 : GE Healthcare: Strategies and Developments
  • Table 93 : Heuron Co., Ltd.: Product Portfolio
  • Table 94 : Heuron Co., Ltd.: Strategies and Developments
  • Table 95 : Imagen: Product Portfolio
  • Table 96 : IBM Corp.: Company Financials, 2019 and 2020
  • Table 97 : IBM Corp.: Product Portfolio
  • Table 98 : IBM Corp.: Strategies and Developments
  • Table 99 : iCarbonX: Product Portfolio
  • Table 100 : Intel Corp.: Product Portfolio in AI Diagnostics
  • Table 101 : Intel Corp.: Company Financials, 2019 and 2020
  • Table 102 : Medtronic Plc: Financials, 2019 and 2020
  • Table 103 : Medtronic Plc: Product Portfolio
  • Table 104 : Medtronic Plc: Strategies and Developments
  • Table 105 : Microsoft Corp.: Financials, 2019 and 2020
  • Table 106 : Microsoft Corp.: Product Portfolio
  • Table 107 : Microsoft Corp.: Strategies and Developments
  • Table 108 : Nano-X AI: Product Portfolio
  • Table 109 : Nano-X AI: Strategies and Developments
  • Table 110 : Nano-X AI: MSaaS Agreements in 2020
  • Table 111 : Nvidia: Company Financials, 2019 and 2020
  • Table 112 : Nvidia: Product Portfolio
  • Table 113 : NVIDIA: Strategies and Developments
  • Table 114 : Phillips Healthcare: Financials, 2019 and 2020
  • Table 115 : Philips Healthcare: Product Portfolio in AI in Diagnostics
  • Table 116 : Phillips Healthcare: Strategies and Developments
  • Table 117 : Qure.ai: Product Portfolio
  • Table 118 : Qure.ai: Strategic Developments
  • Table 119 : F. Hoffmann-La Roche Ltd.: Financials, 2019 and 2020
  • Table 120 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2019 and 2020
  • Table 121 : F. Hoffmann-La Roche Ltd.: Product Portfolio in AI Diagnostics
  • Table 122 : F. Hoffmann-La Roche Ltd.: Recent Developments
  • Table 123 : Samsung Electronics Inc.: Product Portfolio
  • Table 124 : Samsung Electronics Inc.: Strategic Developments
  • Table 125 : Siemens Healthcare GmbH: Product Segments
  • Table 126 : Siemens Healthcare GmbH: AI Diagnostics Products
  • Table 127 : Siemens Healthcare GmbH: Financials, 2019 and 2020
  • Table 128 : Subtle Medical, Inc.: Product Portfolio
  • Table 129 : Subtle Medical, Inc.: Strategies and Developments
  • Table 130 : Synapsica: Product Portfolio
  • Table 131 : Synapsica: Strategies and Developments
  • Table 132 : Xilinx, Inc.: Company Financials, 2019 and 2020
  • Table 133 : Xilinx, Inc.: Product Portfolio
  • Table 134 : Xilinx, Inc.: Strategies and Developments

List of Figures

  • Summary Figure A : Global Market for AI Medical Diagnostics, by Region, 2019-2026
  • Summary Figure B : Global Market Shares of AI Medical Diagnostics, by Region, 2020
  • Figure 1 : Snapshot of the Global Market for AI Medical Diagnostics
  • Figure 2 : Global Market for Artificial Intelligence in Medical Diagnostics: Industry Process Flow
  • Figure 3 : FDA-Approved AI Radiology and Other Imaging Medical Products in the U.S., by Modality, 2018-2021
  • Figure 4 : FDA-Approved AI Radiology and Other Imaging Medical Products in the U.S., by Medical Specialty, 2018-2021
  • Figure 5 : FDA-Approved AI Algorithms for Medical Diagnostics in the U.S., 1995-2021
  • Figure 6 : Shares of FDA-Approved AI Algorithms for Medical Diagnostics in the U.S., by Company, 2018-2021
  • Figure 7 : FDA-Approved AI Algorithms in the U.S., by Medical Specialty, 2018-2021
  • Figure 8 : Global Funding in Health-Tech Companies, 2010-2019
  • Figure 9 : Global Projections for Three Chronic Diseases, 2005-2030
  • Figure 10 : Global Market for AI Medical Diagnostics, by Component, 2019-2026
  • Figure 11 : Global Market Shares of AI Medical Diagnostics, by Component, 2020
  • Figure 12 : Global Market for AI Software in Medical Diagnostics, 2019-2026
  • Figure 13 : Global Market for AI Software in Medical Diagnostics, by Region, 2019-2026
  • Figure 14 : Global Market for AI Services in Medical Diagnostics, 2019-2026
  • Figure 15 : Global Market for AI Services in Medical Diagnostics, by Region, 2019-2026
  • Figure 16 : Global Market for AI Hardware in Medical Diagnostics, 2019-2026
  • Figure 17 : Global Market for AI Hardware in Medical Diagnostics, by Region, 2019-2026
  • Figure 18 : Global Market for AI Medical Diagnostics, by Medical Specialty Application Area, 2019-2026
  • Figure 19 : Global Market Shares of AI Medical Diagnostics, by Medical Specialty Application Area, 2020
  • Figure 20 : Global Deaths from Cancer, 2015 and 2030
  • Figure 21 : Global Market for AI Medical Diagnostics in Oncology, 2019-2026
  • Figure 22 : Global Market for AI Medical Diagnostics in Oncology, by Region, 2019-2026
  • Figure 23 : Global Deaths from CVD, 2015 and 2030
  • Figure 24 : Global Market for AI Medical Diagnostics in Cardiology, 2019-2026
  • Figure 25 : Global Market for AI Medical Diagnostics in Cardiology, by Region, 2019-2026
  • Figure 26 : Global Market for AI Medical Diagnostics in Neurology, 2019-2026
  • Figure 27 : Global Market for AI Medical Diagnostics in Neurology, by Region, 2019-2026
  • Figure 28 : Global Percentage Distribution of Population Aged Above 65, by Region, 2015 and 2050
  • Figure 29 : Global Market for AI Medical Diagnostics in Orthopedics, 2019-2026
  • Figure 30 : Global Market for AI Medical Diagnostics in Orthopedics, by Region, 2019-2026
  • Figure 31 : Global Market for AI Medical Diagnostics in Other Disease Treatments, 2019-2026
  • Figure 32 : Global Market for AI Medical Diagnostics in Other Disease Treatments, by Region, 2019-2026
  • Figure 33 : Global Market for AI Medical Diagnostics, by End User, 2019-2026
  • Figure 34 : Global Market Shares of AI Medical Diagnostics, by End User, 2020
  • Figure 35 : Number of Hospitals in the U.S., by Type, 2020
  • Figure 36 : Global Market for AI in Hospitals and Clinics, 2019-2026
  • Figure 37 : Global Market for AI in Hospital and Clinics, by Region, 2019-2026
  • Figure 38 : Global Market for AI Medical Diagnostics in Diagnostic Imaging Centers and Diagnostic Laboratories, 2019-2026
  • Figure 39 : Global Market for AI Medical Diagnostics in Diagnostic Imaging Centers and Diagnostic Laboratories, by Region, 2019-2026
  • Figure 40 : Global Market for AI Medical Diagnostics, by Modality, 2020
  • Figure 41 : Global Market Shares of AI Medical Diagnostics, by Modality, 2020
  • Figure 42 : Global Market for AI-Based MRI Scans, 2019-2026
  • Figure 43 : Global Market for AI-Based MRI Scans, by Region, 2019-2026
  • Figure 44 : Global Market for AI-Based CT Scans, 2019-2026
  • Figure 45 : Global Market for AI-Based CT Scans, by Region, 2019-2026
  • Figure 46 : Global Market for AI-Based Ultrasound, 2019-2026
  • Figure 47 : Global Market for AI-Based Ultrasound, by Region, 2019-2026
  • Figure 48 : Global Market for AI-Based X-Rays, 2019-2026
  • Figure 49 : Global Market for AI-Based X-Rays, by Region, 2019-2026
  • Figure 50 : Annual Revenues in the Endoscopy Devices Market, 2015-2024
  • Figure 51 : Global Market for AI-Based Other Imaging Techniques, 2019-2026
  • Figure 52 : Global Market for AI-Based Other Imaging Techniques, by Region, 2019-2026
  • Figure 53 : Global Market for AI Medical Diagnostics, by Region, 2019-2026
  • Figure 54 : Global Market Shares of AI Medical Diagnostics, by Region, 2020
  • Figure 55 : North American Market Shares of AI Medical Diagnostics, by Country, 2020
  • Figure 56 : U.S. Market for AI Medical Diagnostics, 2019-2026
  • Figure 57 : Canadian Market for AI Medical Diagnostics, 2019-2026
  • Figure 58 : Rising Geriatric Population in Germany, 2000-2030
  • Figure 59 : German Market for AI Medical Diagnostics, 2019-2026
  • Figure 60 : United Kingdom Market for AI Medical Diagnostics, 2019-2026
  • Figure 61 : French Market for AI Medical Diagnostics, 2019-2026
  • Figure 62 : Italian Market for AI Medical Diagnostics, 2019-2026
  • Figure 63 : Spanish Market for AI Medical Diagnostics, 2019-2026
  • Figure 64 : Rest of the European Market for AI Medical Diagnostics, 2019-2026
  • Figure 65 : Allocation of Diagnosed Infectious Diseases in Selected Countries, by Gender, as of 2019
  • Figure 66 : Chinese Market for AI Medical Diagnostics, 2019-2026
  • Figure 67 : Japanese Market for AI Medical Diagnostics, 2019-2026
  • Figure 68 : Indian Market for AI Medical Diagnostics, 2019-2026
  • Figure 69 : Rest of Asia-Pacific Market for AI Medical Diagnostics, 2019-2026
  • Figure 70 : Rest of the World Market for AI Medical Diagnostics, 2019-2026
  • Figure 71 : Patents Granted to Siemens Healthcare GmbH, 2019-2021
  • Figure 72 : Share of Patents Granted to Siemens Healthcare GmbH, by Geography, 2019-2021
  • Figure 73 : Patents Granted to General Electric Co., 2019-2021
  • Figure 74 : Patents Granted to Other Major Players, 2019-2021
  • Figure 75 : Share of Patents Granted on AI Medical Diagnostics, by Geography, 2019-2021
  • Figure 76 : Share of Start-ups Founded in the AI Medical Diagnostics Industry, by Region, 2020-2021
  • Figure 77 : Key Strategies Followed by Companies, by Type of Strategy, 2018-2021
  • Figure 78 : Key Strategies Followed by Companies, by Type of Strategy, 2018-2021
  • Figure 79 : Number of Strategic Actions Followed, by Company, 2018-2021
  • Figure 80 : Canon Medical: Revenue Share, by Region, 2020
  • Figure 81 : GE: Revenue Share, by Business Segment, 2020
  • Figure 82 : GE Healthcare: Revenue Share, by Region, 2020
  • Figure 83 : IBM Corp.: Revenue Share, by Business Segment in AI Diagnostics, 2020
  • Figure 84 : Intel Corp.: Revenue Share, by Country, 2020
  • Figure 85 : Microsoft Corp.: Revenue Share, by Geography, 2020
  • Figure 86 : Phillips Healthcare: Revenue Share, by Geography, 2020
  • Figure 87 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
  • Figure 88 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Geography, 2019
  • Figure 89 : Siemens Healthcare GmbH: Revenue Share, by Business Segment, 2020
  • Figure 90 : Siemens Healthcare GmbH: Revenue Share, by Region, 2019
  • Figure 91 : Xilinx, Inc.: Revenue Share, by Region, 2020